Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bloomage Biotech is a global leader in the development and production of hyaluronic acid (HA) and other bioactive substances. The company utilizes a proprietary microbial fermentation platform to produce high-quality HA for medical, cosmetic, and food applications. Their product portfolio includes medical aesthetics such as dermal fillers, ophthalmology products, orthopedic injections, and a wide range of raw materials for the global life sciences industry. Bloomage is recognized for its proprietary BLAD-HYA technology, which refers to its unique cross-linking process used in the production of advanced dermal fillers. The company is headquartered in Beijing and maintains a significant global presence with R&D and manufacturing facilities across China and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BLAD-HYA Group.